Rothschild & Co Redburn Issues Positive Forecast for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CME) had its price objective hoisted by Rothschild & Co Redburn from $300.00 to $333.00 in a report issued on Thursday,MarketScreener reports. They currently have a neutral rating on the financial services provider’s stock.

Several other brokerages also recently issued reports on CME. Raymond James Financial cut their price objective on CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Morgan Stanley lifted their price target on shares of CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Argus dropped their target price on shares of CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Bank of America lifted their price objective on shares of CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Finally, TD Cowen upped their price objective on CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $299.53.

CME Group Stock Up 0.5%

Shares of CME Group stock traded up $1.63 during midday trading on Thursday, reaching $303.27. 232,144 shares of the company’s stock traded hands, compared to its average volume of 2,155,175. The company has a market cap of $109.36 billion, a price-to-earnings ratio of 27.17, a price-to-earnings-growth ratio of 3.29 and a beta of 0.27. The company’s 50 day simple moving average is $279.18 and its 200 day simple moving average is $273.80. CME Group has a 52 week low of $244.43 and a 52 week high of $309.35. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $2.52 EPS. CME Group’s quarterly revenue was up 8.1% compared to the same quarter last year. Equities analysts expect that CME Group will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $5.20 annualized dividend and a yield of 1.7%. This is an increase from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio is 44.80%.

Insider Transactions at CME Group

In related news, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the sale, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. This represents a 27.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Dennis Suskind sold 748 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the transaction, the director owned 2,699 shares in the company, valued at $809,700. This represents a 21.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

A number of institutional investors have recently added to or reduced their stakes in CME. Amundi grew its position in CME Group by 24.0% in the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock worth $548,150,000 after purchasing an additional 385,225 shares during the period. Truist Financial Corp raised its stake in shares of CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after buying an additional 5,773 shares during the period. Alley Investment Management Company LLC boosted its position in shares of CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after purchasing an additional 13,512 shares during the period. Elevate Capital Advisors LLC lifted its stake in shares of CME Group by 85.2% during the 3rd quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after buying an additional 3,919 shares in the last quarter. Finally, Victory Financial Group LLC boosted its stake in shares of CME Group by 310.2% in the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after acquiring an additional 2,302 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME declared a higher quarterly dividend ($1.30) and an annual variable dividend totaling $6.15 per share based on 2025 results — a sizable cash return (~$2.2B) that supports income-oriented buyers. Article Title
• Positive Sentiment: Rothschild & Co Redburn lifted its price target on CME to $333 (from $300), implying meaningful upside vs. recent levels even while keeping a “neutral” rating — this can put upward pressure on the stock as investors re‑price expectations. Article Title
• Positive Sentiment: CME is expanding its product set: first trades have occurred in new Cardano, Chainlink and Stellar crypto futures — incremental fee revenue and validation of CME’s crypto platform growth. Article Title
• Positive Sentiment: Reports say CME is exploring a rare‑earths futures contract — entering a strategic commodity niche that could establish a new benchmark and diversify product revenue. Article Title
• Positive Sentiment: Exclusive reporting indicates CME plans to list warehouses in Taiwan and Hong Kong as part of an Asia aluminium push — a regional expansion that could grow physical‑market linkage and volumes. Article Title
• Positive Sentiment: An institutional filing shows Illinois Municipal Retirement Fund increased its stake in CME materially — institutional buying can be supportive for the stock. Article Title
• Neutral Sentiment: CFTC formed an Innovation Advisory Committee that includes industry leaders and representatives from exchanges (including CME) — helps shape regulation and future market structure but impact on near‑term revenue is indirect. Article Title
• Neutral Sentiment: CME announced its slate of board director nominees — governance update material for shareholders but not an immediate earnings driver. Article Title
• Neutral Sentiment: Analysis and Q&A pieces from earnings provide context on growth drivers and margin outlook — useful for modeling but not new company announcements. Article Title
• Neutral Sentiment: Short‑interest reports in the feed show anomalous “0” and NaN values — the data appears inconsistent and isn’t a reliable signal of bearish positioning.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.